Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

Xin Wang Biography and Net Worth

SVP of Boston Scientific

Mr. Wang recently served as general manager of the Orthopedics group at Johnson & Johnson Medical China. His tenure at Johnson & Johnson spanned more than 10 years and included several leadership positions at both the Ethicon Endo-Surgery and DePuy franchises. During his time at Johnson & Johnson, he spearheaded the launch of the company’s new infection prevention business known as the Advanced Sterilization Products franchise, growing it to become the market leader for low temperature sterilization in China. As a result of his achievements, Mr. Wang moved on to manage the growth and development of Johnson & Johnson’s orthopedics and neurosciences franchise, ultimately achieving significant financial growth by building a culture of teamwork, creating an innovative direct-to-consumer marketing campaign, and forming strategic partnerships with government authorities and medical associations. He was promoted to vice president in January 2006 and became a board member of Johnson & Johnson Medical China. Prior to Johnson & Johnson, Mr. Wang held positions at the China Foreign Trade Development Co. and BP Amoco.

Mr. Wang earned a bachelor’s degree in Economics from the University of International Business and Economics, Beijing and a master’s degree in business administration in Marketing and Finance from the University of Chicago.

How do I contact Xin Warren Wang?: The corporate mailing address for Mr. Wang and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected]. Learn More on Xin Warren Wang's contact information.
Has Xin Warren Wang been buying or selling shares of Boston Scientific?: Xin Warren Wang has not been actively trading shares of Boston Scientific during the past quarter. Most recently, Xin Warren Wang sold 10,000 shares of the business's stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $38.45, for a transaction totalling $384,500.00. Learn More on Xin Warren Wang's trading history.
Who are Boston Scientific's active insiders?: Boston Scientific's insider roster includes Kevin Ballinger (EVP), Supratim Bose (EVP), Daniel Brennan (CFO), Vance Brown (SVP), Arthur Butcher (EVP), Wendy Carruthers (SVP), Nelda Connors (Director), Keith Dawkins (EVP), Charles Dockendorff (Director), Jodi Eddy (SVP), Joseph Fitzgerald (EVP), Edward Ludwig (Director), Edward Ludwig (Director), Edward Mackey (EVP), Michael Mahoney (CEO), Ian Meredith (EVP), Jeffrey Mirviss (EVP), Jonathan Monson (CAO), Maulik Nanavaty (SVP), Scott Olson (SVP), Michael Phalen (EVP), David Pierce (EVP), Timothy Pratt (EVP), Desiree Ralls-Morrison (SVP), Meghan Scanlon (SVP), John Sorenson (SVP), Eric Thepaut (EVP), Xin Wang (SVP), and David Wichmann (Director). Learn More on Boston Scientific's active insiders.
Are insiders buying or selling shares of Boston Scientific?: During the last twelve months, insiders at the medical equipment provider sold shares 21 times. They sold a total of 481,676 shares worth more than $37,970,807.37. The most recent insider tranaction occured on October, 7th when CEO Michael F Mahoney sold 162,777 shares worth more than $13,775,817.51. Insiders at Boston Scientific own 0.5% of the company. Learn More about insider trades at Boston Scientific.
Information on this page was last updated on 10/7/2024.

Xin Warren Wang Insider Trading History at Boston Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/3/2019	Sell	10,000	$38.45	$384,500.00
3/1/2019	Sell	10,000	$40.31	$403,100.00
12/3/2018	Sell	10,000	$38.00	$380,000.00

Xin Warren Wang Buying and Selling Activity at Boston Scientific

Boston Scientific Company Overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $90.50

$90.36

$90.72

50 Day Range

MA: $85.71

$82.52

$90.45

2 Week Range

Now: $90.50

$53.93

$91.08

Volume

139,253 shs

Average Volume

6,062,281 shs

Market Capitalization

$133.38 billion

P/E Ratio

74.79

Dividend Yield

N/A

Beta

0.79

Trump said you could learn something from this man

From Wide Moat Research | Ad

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.